Background Endometriosis is a risk factor for epithelial ovarian cancer; however, whether
this risk extends to all invasive histological subtypes or borderline tumours is not clear. We …

Background Breast cancer patients with tumors that are estrogen receptor (ER)-positive and/or
progesterone receptor (PR)-positive have lower risks of mortality after their diagnosis …

Background Case reports and the results of a recent case-control study have raised
questions about the potential neoplastic effects of medications used as treatment for infertility. …

TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of
multiple cancers. Using the Illumina custom genotyping array iCOGs, we analyzed ∼480 …

Background The understanding of ovarian cancer pathogenesis has recently shifted to
recognize distinct changes in how ovarian cancer histotypes are defined. Using the 2014 World …

Genome-wide association studies (GWAS) have identified four susceptibility loci for
epithelial ovarian cancer (EOC), with another two suggestive loci reaching near genome-wide …

Ovarian cancer accounts for more deaths than all other gynecological cancers combined.
To identify common low-penetrance ovarian cancer susceptibility genes, we conducted a …

Epithelial ovarian cancer has a major heritable component, but the known susceptibility
genes explain less than half the excess familial risk 1 . We performed a genome-wide …

Epithelial ovarian cancer (EOC) is the leading cause of death from gynecological malignancy
in the developed world, accounting for 4% of the deaths from cancer in women 1 . We …

Objective. —To determine the risk of breast cancer in relation to the use of combined estrogen
and progestin hormone replacement therapy (HRT). Design. —A population-based case-…